|
|
Value |
Agea |
Agea |
69.
0 (66.0-72.0) |
BMIa |
BMIa |
25.
4 (23.5-27.6) |
Genderb |
Female |
61
(47.3%) |
|
Male |
68 (52.7%) |
History of ESWLb |
Absent |
100
(77.5%) |
|
Present |
29 (22.5%) |
Metabolic Syndromeb |
Absent |
88
(68.2%) |
|
Present |
41 (31.8%) |
Stone Localizationb |
Lower pole |
20 (15.5%) |
|
Middle pole |
5 (3.8%) |
|
Upper pole |
5 (3.8%) |
|
Pelvis |
46 (35.6%) |
|
Proximal ureter |
26 (20.1%) |
|
Multiple calyxes |
27 (20.9%) |
Preoperative Hydronephrosisb |
None |
45 (34.9%) |
|
Grade 1 |
59 (45.7%) |
|
Grade 2 |
22 (17.1%) |
|
Grade 3 |
3 (2.3%) |
Ureteral Wall Thicknessa (mm) |
Ureteral Wall Thicknessa (mm) |
1.90
(1.7-2.4) |
Preoperative Pelvis Urine Densitya (HU) |
Preoperative Pelvis Urine Densitya (HU) |
7.0
(-4.0-9.0) |
Stone Densitya (HU) |
Stone
Densitya (HU) |
1039. 0 (751.0-1223.0) |
Stone Sizea (mm) |
Stone
Sizea (mm) |
90. 0 (80.0-130.0) |
Postoperative stentb |
None |
17
(13.2%) |
|
Ureteral catheter |
12 (9.3%) |
|
Double-J stent |
100 (77.5%) |
Postoperative Complicationb |
None |
121 (93.7%) |
|
Fewer |
7 (5.4%) |
|
Perforation |
0 |
|
Sepsis |
1 (0.7%) |
|
Death |
0 |
Operation Timea (min) |
Operation
Timea (min) |
65. 0 (50.0-70.0) |
Hospitalization Datea(day) |
Hospitalization Datea(day) |
2. 0
(2.0-3.0) |
Residual Fragmentb |
Absent |
90
(69.7%) |
|
Present |
14 (10.8%) |
|
CIRF |
25 (18.6%) |